Pyxis Oncology, Inc. (PYXS) DCF Valuation

Pyxis Oncology, Inc. (PYXS) DCF Valuation
  • ✓ Fully Editable: Tailor To Your Needs In Excel Or Sheets
  • ✓ Professional Design: Trusted, Industry-Standard Templates
  • ✓ Pre-Built For Quick And Efficient Use
  • ✓ No Expertise Is Needed; Easy To Follow

Pyxis Oncology, Inc. (PYXS) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Enhance your investment strategies with the [Symbol] DCF Calculator! Utilize real Pyxis Oncology financial data, adjust growth projections and expenses, and instantly observe how these adjustments affect [Symbol] intrinsic value.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 -12.4 -69.1 -122.8 -78.5 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation 2.9 .4 1.3 1.8 2.0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -2.9 -12.9 -70.3 -124.6 -80.5 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash 19.7 8.1 274.7 179.3 119.3 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .6 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .9 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .5 1.1 12.0 7.1 3.9 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 -1.5 -.5 -6.4 -6.7 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -2.8 -12.8 -75.5 -121.8 -80.5 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .6 -13.3 -63.9 -132.6 -87.0 -3.9 .0 .0 .0 .0
WACC, % 8.91 8.95 8.96 8.93 8.96 8.94 8.94 8.94 8.94 8.94
PV UFCF
SUM PV UFCF -3.6
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -4
Net Debt 12
Equity Value -15
Diluted Shares Outstanding, MM 40
Equity Value Per Share -0.38

What You Will Get

  • Editable Excel Template: A fully customizable Excel-based DCF Calculator featuring pre-filled real PYXS financials.
  • Real-World Data: Historical data and forward-looking estimates (as indicated in the yellow cells).
  • Forecast Flexibility: Adjust forecast assumptions such as revenue growth, EBITDA %, and WACC.
  • Automatic Calculations: Instantly observe the effect of your inputs on Pyxis Oncology’s valuation.
  • Professional Tool: Designed for investors, CFOs, consultants, and financial analysts.
  • User-Friendly Design: Organized for clarity and ease of use, complete with step-by-step instructions.

Key Features

  • 🔍 Real-Life PYXS Financials: Pre-filled historical and projected data for Pyxis Oncology, Inc.
  • ✏️ Fully Customizable Inputs: Adjust all critical parameters (yellow cells) like WACC, growth %, and tax rates.
  • 📊 Professional DCF Valuation: Built-in formulas calculate Pyxis Oncology’s intrinsic value using the Discounted Cash Flow method.
  • ⚡ Instant Results: Visualize Pyxis Oncology’s valuation instantly after making changes.
  • Scenario Analysis: Test and compare outcomes for various financial assumptions side-by-side.

How It Works

  • Download: Get the pre-prepared Excel file featuring Pyxis Oncology, Inc.'s (PYXS) financial metrics.
  • Customize: Modify projections such as revenue growth, EBITDA %, and WACC according to your analysis.
  • Update Automatically: The intrinsic value and NPV calculations refresh in real-time as you make changes.
  • Test Scenarios: Develop various forecasts and evaluate different outcomes instantly.
  • Make Decisions: Utilize the valuation insights to inform your investment approach.

Why Choose This Calculator for Pyxis Oncology, Inc. (PYXS)?

  • Accurate Data: Up-to-date Pyxis Oncology financials provide dependable valuation outcomes.
  • Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to fit your forecasts.
  • Time-Saving: Ready-to-use calculations save you from starting from the ground up.
  • Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
  • User-Friendly: Clear layout and guided instructions ensure accessibility for all users.

Who Should Use This Product?

  • Investors: Accurately assess Pyxis Oncology's fair value before making investment decisions.
  • CFOs: Utilize a professional-grade DCF model for financial reporting and analysis related to Pyxis Oncology.
  • Consultants: Easily customize the template for valuation reports focused on Pyxis Oncology for clients.
  • Entrepreneurs: Acquire knowledge about financial modeling practices utilized by leading biotech firms.
  • Educators: Employ it as a teaching resource to illustrate valuation methodologies in the biotech sector.

What the Template Contains

  • Pre-Filled Data: Includes Pyxis Oncology's historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on custom inputs.
  • Key Financial Ratios: Analyze Pyxis Oncology's profitability, efficiency, and leverage.
  • Customizable Inputs: Edit revenue growth, margins, and tax rates with ease.
  • Clear Dashboard: Charts and tables summarizing key valuation results.

Es wurden keine passenden Produkte gefunden.